Free US stock earnings trajectory analysis and revision trends to understand fundamental momentum. We track how analyst estimates have been changing over time to gauge improving or deteriorating expectations.
As of 2026-04-20, United Therapeutics Corporation (UTHR) trades at a current price of $573.44, marking a 2.54% decline in recent trading. This analysis explores key technical levels for UTHR, prevailing market context for the biotech sector, and potential short-term price scenarios for the stock, without providing any investment recommendations. Recent price action for UTHR has been largely range-bound, with traders focusing on two key price points that have acted as consistent barriers to both
United (UTHR) Stock Delisting (Risk Aversion) 2026-04-20 - Fast Rising Picks
UTHR - Stock Analysis
4163 Comments
886 Likes
1
Gabrielah
Elite Member
2 hours ago
Anyone else here for the same reason?
๐ 205
Reply
2
Emzie
Power User
5 hours ago
Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
๐ 166
Reply
3
Carlyn
Loyal User
1 day ago
The market is navigating between support and resistance levels.
๐ 37
Reply
4
Dezman
Legendary User
1 day ago
Market is holding support levels, which is encouraging for trend continuation.
๐ 51
Reply
5
Lazuli
Power User
2 days ago
The market is consolidating near key price levels, waiting for further catalysts to drive direction.
๐ 246
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.